Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Free Cash Flow (2020 - 2025)

Sight Sciences has reported Free Cash Flow over the past 6 years, most recently at -$1.7 million for Q4 2025.

  • Quarterly results put Free Cash Flow at -$1.7 million for Q4 2025, up 53.53% from a year ago — trailing twelve months through Dec 2025 was -$29.9 million (down 31.59% YoY), and the annual figure for FY2025 was -$29.9 million, down 31.59%.
  • Free Cash Flow for Q4 2025 was -$1.7 million at Sight Sciences, up from -$8.9 million in the prior quarter.
  • Over the last five years, Free Cash Flow for SGHT hit a ceiling of $311000.0 in Q3 2024 and a floor of -$22.2 million in Q1 2022.
  • Median Free Cash Flow over the past 5 years was -$11.2 million (2021), compared with a mean of -$11.5 million.
  • Biggest five-year swings in Free Cash Flow: surged 103.07% in 2024 and later crashed 2958.2% in 2025.
  • Sight Sciences' Free Cash Flow stood at -$10.9 million in 2021, then plummeted by 43.68% to -$15.6 million in 2022, then surged by 56.83% to -$6.7 million in 2023, then skyrocketed by 46.71% to -$3.6 million in 2024, then soared by 53.53% to -$1.7 million in 2025.
  • The last three reported values for Free Cash Flow were -$1.7 million (Q4 2025), -$8.9 million (Q3 2025), and -$7.8 million (Q2 2025) per Business Quant data.